• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CODMAN AND SHURTLEFF, INC STENT - VASCULAR RECONSTRUCTION; INTRACRANIAL NEUROVASCULAR STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CODMAN AND SHURTLEFF, INC STENT - VASCULAR RECONSTRUCTION; INTRACRANIAL NEUROVASCULAR STENT Back to Search Results
Catalog Number UNKENTERPRISEENC
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Death (1802); Thromboembolism (2654); No Code Available (3191)
Event Date 01/31/2016
Event Type  Death  
Manufacturer Narrative
(b)(4).Aneurysm rupture.Since the product was not returned for analysis, no product failure analysis can be conducted and no determination of possible contributing factors could be made.Device history record (dhr) review cannot be conducted because the no lot number was provided by the customer.This is one of six products involved with the reported complaint and the associated manufacturer report numbers are 1226348-2019-00959, 1226348-2019-00960, 1226348-2019-00961, 1226348-2019-00962, 1226348-2019-00963, and 1226348-2019-00964.
 
Event Description
This complaint is from a literature source.As reported in the literature publication entitled, ¿stent assisted coil embolization of anterior communicating artery aneurysms: safety, effectiveness, and risk factors for procedural complications or recanalization¿, 2 patients with anterior communicating artery aneurysm who underwent stent assisted coil embolization with enterprise stent died due to ruptured aneurysms and thromboembolic complications.This study was undertaken to assess the safety and effectiveness of sac embolization in treating acoa aneurysms and to determine risk factors for related procedural complications or recanalization.Methods between august 2008 and december 2016, 184 patients with acoa aneurysms were treated with sac embolization.Cumulative medical record and radiologic data were analyzed using binary logistic regression to identify factors predisposing to procedural complications or recanalization.
 
Manufacturer Narrative
This is a correction of the previous submission report related to the literature article entitled ¿stent assisted coil embolization of anterior communicating artery aneurysms: safety, effectiveness, and risk factors for procedural complications or recanalization".The product code was updated from unkenterpriseenc to unkenterpriseenf.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STENT - VASCULAR RECONSTRUCTION
Type of Device
INTRACRANIAL NEUROVASCULAR STENT
Manufacturer (Section D)
CODMAN AND SHURTLEFF, INC
325 paramount dr
raynham MA 02767
Manufacturer (Section G)
SEE H10
circuito interior norte #1820
juarez chihuahua
MX  
Manufacturer Contact
gabriel alfageme
31 technology drive
irvine, CA 92618
949789-868
MDR Report Key8814368
MDR Text Key151836085
Report Number1226348-2019-00961
Device Sequence Number1
Product Code NJE
Combination Product (y/n)N
Reporter Country CodeKS
PMA/PMN Number
UNK
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,literature
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 07/01/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/22/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNKENTERPRISEENC
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/07/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age59 YR
-
-